Form 10-KT - Transition reports [Rule 13a-10 or 15d-10]:
SEC Accession No. 0001213900-15-007370
Filing Date
2015-09-28
Accepted
2015-09-29 23:13:07
Documents
19
Period of Report
2015-06-30

Document Format Files

Seq Description Document Type Size
1 TRANSITION REPORT f10kt2015_dandritbio.htm 10-KT 1228504
2 CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO SECTION 302 OF THE SARBANES f10kt2015ex31i_dandritbio.htm EX-31.1 12017
3 CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO SECTION 302 OF THE SARBANES f10kt2015ex31ii_dandritbio.htm EX-31.2 11957
4 CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION f10kt2015ex32i_dandritbio.htm EX-32.1 5105
5 GRAPHIC image_001.jpg GRAPHIC 29567
6 GRAPHIC image_002.jpg GRAPHIC 28027
7 GRAPHIC image_003.jpg GRAPHIC 34408
8 GRAPHIC image_009.jpg GRAPHIC 7409
9 GRAPHIC image_005.jpg GRAPHIC 50321
10 GRAPHIC image_006.jpg GRAPHIC 55507
11 GRAPHIC image_007.jpg GRAPHIC 15416
12 GRAPHIC image_008.jpg GRAPHIC 6099
13 GRAPHIC img_017.jpg GRAPHIC 29911
  Complete submission text file 0001213900-15-007370.txt   4775596

Data Files

Seq Description Document Type Size
14 XBRL INSTANCE FILE ddrt-20150630.xml EX-101.INS 579391
15 XBRL SCHEMA FILE ddrt-20150630.xsd EX-101.SCH 48827
16 XBRL CALCULATION FILE ddrt-20150630_cal.xml EX-101.CAL 48390
17 XBRL DEFINITION FILE ddrt-20150630_def.xml EX-101.DEF 107459
18 XBRL LABEL FILE ddrt-20150630_lab.xml EX-101.LAB 402159
19 XBRL PRESENTATION FILE ddrt-20150630_pre.xml EX-101.PRE 255437
Mailing Address DANDRIT BIOTECH A/S FRUEBJERGVEJ 3 BOX 62 2100 COPENHAGEN G7
Business Address DANDRIT BIOTECH A/S FRUEBJERGVEJ 3 BOX 62 2100 COPENHAGEN G7 45 39179840
DanDrit Biotech USA, Inc. (Filer) CIK: 0001527728 (see all company filings)

EIN.: 452259340 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-KT | Act: 34 | File No.: 000-54478 | Film No.: 151132119
SIC: 2834 Pharmaceutical Preparations